O‘PKA TUBERKULYOZI TASHXISINING ZAMONAVIY HOLATI
Keywords:
tuberkulyoz kasalligi, diagnostika, differentsial diagnostikadagi xatolarAbstract
Adabiy ma'lumotlarni tahlil qilish o'pka tuberkulyozining differentsial tashxisida doimiy qiyinchiliklar mavjudligini ko'rsatadi. O'pka
tuberkulyozi, o'pkaning xavfli o'smalari, pnevmoniya va nafas olish organlarining sarkoidozida birlamchi va aniqlangan tashxislar o'rtasidagi nomuvofiqlik darajasi 16,7% dan 97,1% gacha [24;37].
References
1.
Aktogu S. Clinical spectrum of pulmonary and pleural tuberculosis: a report of
5,480 cases / S. Aktogu, A. Yorgancioglu, K. Cirak // Eur. Respir. J. - 1996. 9(10). P.
2031-2035
2.
Amicosante M., Houde M., Guaraldi G., Saltini C. // International Journal
Tuberculosis Lung Diseases, 1999, Vol. 6, №6, P. 736-740
3.
Amiri M. Evaluation of the combined use of polymerase chain reaction and
adeno¬sine deaminase activity on the diagnosis of pleural tuberculosis / M. Amiri, S.
Mansouri, S. Mirsaeidi // Europ. Resp. J. 2005. Suppl. 40, Vol. 26. P. 2657
4.
Andreasyan N. A., Hairapetian, H. L., Sargisova, Y. G. et al. Activity of
adenosine deaminase and its isoforms in pleural fluid in tuberculous pleuritis // Med.
Sci. Monit. 2002. Vol. 8, N 10. P. CR708 – CR712;
5.
Andreu J. Radiological manifestations of pulmonary tuberculosis / J. Andreu, J.
Ca- ceres, E. Pallisa, M. Martinez-Rodriguez//Eur. J. Radiol. -2004. - 51(2). -P. 139
149
6.
Arif R., Misbahul, I., Abrar, A. et al. Serum adenosine deaminase (ADA) level
in the cases of tuberculous pleural effusion // Pakistan. J. Med. Res. 2002. Vol. 41, N
3, P. 110 – 116
7.
Burgess L. Use of adenosine deaminase as a diagnostic tool for tuberculous
pleurisy /L. Burgess,F. Maritz, I. LeRoux, et al. //Thorax.- 1995. - Vol. 50.-P. 672-674 8.
Chen M. L., Yu, W. C., Lam, C. W. et al. Diagnostic value of pleural fluid
adenosine deaminase activity in tuberculous pleurisy // Clin. Chem. Acta. 2004. Vol.
341. P. 101 – 107
9.
Chittiprol S. Plasma adenosine deaminase activity among HIVI Clade C
seroposi¬tives: relation to CD4 T cell population and antiretroviral therapy / S.
Chittiprol, P. Sat- ishchandra, R.S. Bhimasenaraoet. al. // Clin. Chim. Acta. - 2007. -
Vol. 377. - №1-2. - P. 133-137
10. Global Tuberculosis Report 2013, WHO, Geneva, Switzerland
11. GorgunerM., Cerci, M., Gorguner, I. Determination of adenosine deaminase
activity and its isoenzymes for diagnosis of pleural effusions // Respirology. 2000. Vol.
5. P. 321 – 324
12. Hagmar L. Impact of lymphocyte chromosomal aderrations on human cancer
risk: results from Nordic and Italian cohorts / L. Hagmar, U. Strornberg, S. Bonassi //
Cancer Res. - 2004. - Vol. 64. - P. 2258-2263
13. Hiraki A., Aoe, K., Eda, R. et al. Comparison of six biological markers for the
diagnosis of tuberculous pleuritis // Chest. 2004. Vol. 125. P. 987 – 989
14. Perez-Rodriquez E., Castro, D.J. The use of adenosine deaminase and adenosine
deaminase isoenzymes in the diagnosis of tuberculous pleuritis // Current Opinion in
Pulm. Med. 2000. Vol. 6. P. 259 – 266
15. Hiraki A., Aoe, K., Eda, R. et al. Comparison of six biological markers for the
diagnosis of tuberculosis pleuritis // Chest. 2004. Vol. 125. P. 987 – 989
16. Hsu W.H., Chiang, CD, Chen, WT. et al. Diagnostic value of adenosine
deaminase and gamma-interferon in tuberculous and malignant pleural effusions //
Formosan Medical Association. 1989. Vol. 88(9). P. 879 – 82
17. Inase N. Adenosine deaminase-2 in the diagnosis of tuberculous pleuritis / N.
Inase, S. Tominaga, M. Yasui, Y. Tsukada, M. Oukouchi, H. Miura // Kekkaku. - 2005. - 80(12).-P. 31-3418. Таганович А.Д., Саид М. Алинежад «Диагностические характеристики
аденозиндезаминазного теста у больных туберкулезным плевритом – жителей
Белорусии», Проблема туберкулеза и болезни легких, 2008, №8, С. 38-41
19. Малиев Б.М. Роль патологии трахеобронхиального дерева в
эффективности ле¬чения туберкулеза легких / Б.М. Малиев, М.П. Грачева, ДЛ.
Беляев, A.C. Габараев // Проблемы туберкулеза и болезней легких. 2007. №8. С.
19-25
20. Luis, V., David, A., Esther, S. J. et al. Tuberculous Pleurisy // Arch Intern Med.
1998. Vol. 158. P. 2017 – 2021
21. Hsu W.H., Chiang, CD, Chen, WT. et al. Diagnostic value of adenosine
deaminase and gamma-interferon in tuberculous and malignant pleural effusions //
Formosan Medical Association. 1989. Vol. 88(9). P. 879 – 82
22. Парпиева Н.Н., Мухтаров Д.З., Белоцерковец В.Г. и др. Функция легких и
сердечно-сосудистой системы у больных с лекарственно-устойчивым
туберкулезом легких // Вестник ассоциации пульмонологов Центральной Азии,
2007, №10, С. 70-74
23. Giusti G., Galanti, B. // Methods of enzymatic analysis. 1984. Vol. 4. P. 315 –
323
24. Global Tuberculosis Report 2013, WHO, Geneva, Switzerland
25. Akhtamovna K. N. Fibrotic Complications in the Lungs in Patients Who Have
Had COVID-19 Pathogenesis of COVID-19 //European Journal of Life Safety and
Stability (2660-9630). – 2021. – Т. 9. – С. 14-24.
26. Abdullayevna R. S. CLINICAL AND RADIOLOGICAL FEATURES OF
NEWLY DETECTED PULMONARY TUBERCULOSIS IN PATIENTS WITH
CONCOMITANT DISEASES //Intent Research Scientific Journal. – 2023. – Т. 2. –
№. 3. – С. 45-56.
27. Abdullaevna, R. S., & Rakhmanovich, M. B. (2023). Immunological Features of
Pulmonary Tuberculosis in Patients with Drug Resistance. Scholastic: Journal of
Natural and Medical Education, 2(4), 40-57.28. Муаззамов Б. Р., Муаззамов Б. Б., Медведева Н. В. ПРИМЕНЕНИЕ
ИНТЕРАКТИВНЫХ ПЕДАГОГИЧЕСКИХ МЕТОДОВ ПРЕПОДАВАНИЯ
ПРЕДМЕТА" ФТИЗИАТРИЯ" НА ПРИМЕРЕ ТЕМЫ" ДЕСТРУКТИВНЫЕ
ФОРМЫ ТУБЕРКУЛЁЗА ЛЁГКИХ" //Новый день в медицине. –2019. –No. 3.
С. 45-50.
29. Рустамова С. А. и др. Изучение причин и факторов, способствующих
развитию рецидивов туберкулеза органов дыхания //Медицинский альянс.
2015. –No. 1. –С. 115-115.
